Biopôle Clermont-Limagne
Technology park for life sciences

The Biopôle Clermont-Limagne is a technopole (science technology park), fully dedicated to hosting and supporting businesses working in life sciences, spread over three sites located in Riom, Saint-Beauzire and Clermont-Ferrand.

Biopôle Clermont-Limagne offers biotech entrepreneurs a comprehensive range of services: not only equipped premises but also project support, communication, activities, access to partner networks, services to businesses and to their employees.  Over 50 businesses and organisations are currently growing their activities there.

DIRECTORY
of Biopôle
Clermont-Limagne
companies and
organisations

Do a search

Biopôle news

Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?
5 April 2022

Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?

Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.
1 April 2022

Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.

Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.
14 February 2022

Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.

The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.
21 December 2021

The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.

STRAINCHEM enters the semi-industrial phase with France Relance.
17 December 2021

STRAINCHEM enters the semi-industrial phase with France Relance.

Carbios receives support from the European Commission through the LIFE program.
29 November 2021

Carbios receives support from the European Commission through the LIFE program.

Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.
19 November 2021

Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.

Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.
11 October 2021

Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.

Valbiotis obtains patent for its active substance TOTUM-63 in China.
25 May 2021

Valbiotis obtains patent for its active substance TOTUM-63 in China.

See more news

Briefing

13 May 2022

Limagrain is starting its recruitment campaign! 600 seasonal crops are expected for its summer and autumn harvests.

See the briefing
28 Apr 2022

Valbiotis announces the first visit of the first patient in the TOTUM•63 mode of action clinical study

See the briefing
15 Apr 2022

Aptys Pharma is recruiting a Quality Control Technician.

See the briefing
METabolic Explorer
08 Apr 2022

METabolic EXplorer announces the signing of a Term Sheet for €100 million in syndicated financing to support the Group’s growth (in french)

See the briefing
29 Mar 2022

Valbiotis announces the positive results of its clinical study on the bioavailability and mode of action of TOTUM•070,against hypercholesterolemia.

See the briefing
22 Mar 2022

Valbiotis is strengthening its commitment to CSR by joining the United Nations Global Compact and applying the ISO 26000 standard.

See the briefing
All the briefing